Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00224315
Status:
COMPLETED
Last Update Posted:
2008-06-04
First Post:
2005-09-15
Brief Title:
Clozapine-Augmentation With Ziprasidone or Risperidone a Randomized Prospective Trial
Sponsor:
Central Institute of Mental Health Mannheim
Organization:
Central Institute of Mental Health Mannheim
Study Overview
Official Title:
Clozapine-Augmentation With Ziprasidone or Risperidone a Randomized Prospective Trial
Status:
COMPLETED
Status Verified Date:
2008-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
We aim to compare the augmentation of clozapine with ziprasidone or risperidone in a randomized prospective manner
Detailed Description:
Partial response of schizophrenic psychoses to a monotherapy with clozapine is a frequent problem of clinical psychiatry Current problems are treatment resistant positive andor negative symptoms as well as side effects Therefore different strategies of augmentations have been applied Based on successful experiences in case reports and results of other work groups we aim to compare the augmentation of clozapine with ziprasidone or risperidone in a randomized prospective manner
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None